{name}
{subtitle}
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)
city
~11 mi. (Siedlce, Poland, +130 more cities)
facility
Urologica Praktyka Lekarska Adam Marcheluk ( Site 0654)
drug
BCG solution, +1 more drug
Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)
city
~67 mi. (Otwock, Poland, +159 more cities)
facility
Europejskie Centrum Zdrowia Otwock ( Site 1057)
drug
cisplatin, +2 more drugs
drug type
chemotherapy, +1 more type
Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)
city
~78 mi. (Lublin, Poland, +199 more cities)
facility
Samodzielny Publiczny Szpital Kliniczny nr 1 w Lublinie ( Site 0620)
Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome
city
~78 mi. (Lublin, Poland, +201 more cities)
facility
Samodzielny Publiczny Szpital Kliniczny Nr 1 w Lublinie /ID# 221667
drug
azacitidine, +1 more drug
Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)
city
~82 mi. (Warsaw, Poland, +89 more cities)
facility
Centrum Medyczne Ostrobramska NZOZ Magodent ( Site 1808)
biomarker
ER Positive, +2 more biomarkers
drug
capecitabine, +4 more drugs
drug type
chemotherapy, +1 more type
A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)
city
~98 mi. (Radom, Poland, +144 more cities)
facility
Radomskie Centrum Onkologii ( Site 2418)
drug
belzutifan, +3 more drugs
drug type
immunotherapy, +1 more type